EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of Single‐Breath and Multi‐Breath Xe‐ MRI in the Longitudinal Assessment of Treatment in Children With Cystic Fibrosis

Faiyza S Alam iD, Samal Munidasa iD, Brandon Zanette, Daniel Li, Sharon Braganza, Felix Ratjen iD, Giles Santyr iD

Journal of Magnetic Resonance Imaging · 2026

DOI: 10.1002/jmri.70242 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Magnetic Resonance Imaging, 2026. Verfasst von Faiyza S Alam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Cystic Fibrosis, Magnetic Resonance Imaging. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Cystic Fibrosis Foundation, Hospital for Sick Children.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elexacaftor/tezacaftor/ivacaftor (ETI) is a current standard therapy for pediatric cystic fibrosis (CF). Multiple‐breath washout 129 Xe MRI (MBW Xe‐MRI) is improved following 1 month of treatment. However, the utility of MBW Xe‐MRI over extended ETI treatment and its comparison to single‐breath Xe‐MRI and pulmonary function tests (PFTs) in monitoring disease progression remains unclear.

Purpose

To compare MBW Xe‐MRI and single‐breath Xe‐MRI in a small pediatric CF cohort at 1, 6, 12, and 24 months post‐ETI initiation. Study Type Prospective longitudinal cohort study. Subjects 14 participants (7 female, median age 15.5 [14, 17] years) with CF undergoing ETI. Field Strength/Sequence Xe‐MRI using a gradient echo sequence at 3T. Assessment A total of 12 participants completed MBW Xe‐MRI, single‐breath Xe‐MRI, and PFTs (spirometry, N 2 MBW) at ≥ 2 of 4 visits (1, 6, 12, and 24 months post‐ETI). Fractional ventilation (FV) and FV coefficient of variation (CoV FV ) maps were calculated from MBW Xe‐MRI. Ventilation defect percent (VDP) was calculated from single‐breath Xe‐MRI. Statistical Tests Longitudinal changes were analyzed using a linear mixed‐effects model (fixed effect: time, random intercept: participant). Significance via ANOVA F‐test, p < 0.05. Intra‐class correlation coefficients (ICC) were used to quantify between‐ and within‐subject variability.

Results

Data completeness (total number of acquired data points divided by expected data points across 14 participants, 4 visits) was ≥ 75%. While PFTs/VDP remained stable over 24 months (ICC ≥ 0.93; linear mixed‐effects model of time effect for ppFEV 1 , LCI and VDP was not significant with p = 0.68, 0.13 and 0.12, respectively), CoV FV demonstrated a small but significant increase (slope magnitude +0.001/month). Furthermore, two participants had elevated CoV FV despite normal VDP. Finally, MBW Xe‐MRI metrics showed higher within‐subject variability than PFTs/VDP (ICC: FV = 0.41, CoV FV = 0.55 vs. VDP/PFTs ≥ 0.92). Data Conclusion CoV FV may continue to evolve over 2 years in pediatric CF patients receiving ETI, particularly in individuals with persistent ventilation defects. Evidence Level 1. Stage of Technical Efficacy 2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisMagnetic Resonance ImagingHumansFemaleAdolescentLongitudinal StudiesMaleProspective StudiesRespiratory Function TestsXenon IsotopesChildLungQuinolonesAminophenols

Stichwörter der Autor:innen

cystic fibrosisfractional ventilationhyperpolarized 129Xelung clearance indexmultiple‐breath washout

Substanzen

Xenon IsotopesQuinoloneshyperpolarized Xe-129Aminophenols

Autor:innen und Institutionen

  • Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Translational Medicine Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Division of Respirology, The Hospital for Sick Children, Toronto, Ontario, Canada.

ORCID-Profile: Faiyza S Alam, Samal Munidasa, Felix Ratjen, Giles Santyr

Förderung

  • CIHR
  • Cystic Fibrosis Foundation
  • Hospital for Sick Children
  • Canadian Institutes of Health Research

Zitieren

APA

Alam, F. S., Munidasa, S., Zanette, B., Li, D., Braganza, S., Ratjen, F., & Santyr, G. (2026). Comparison of Single‐Breath and Multi‐Breath Xe‐ MRI in the Longitudinal Assessment of Treatment in Children With Cystic Fibrosis. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.70242

Vancouver

Alam FS, Munidasa S, Zanette B, Li D, Braganza S, Ratjen F, et al. Comparison of Single‐Breath and Multi‐Breath Xe‐ MRI in the Longitudinal Assessment of Treatment in Children With Cystic Fibrosis. Journal of Magnetic Resonance Imaging. 2026. doi:10.1002/jmri.70242

BibTeX
@article{Alam2026,
  author = {Alam, Faiyza S and Munidasa, Samal and Zanette, Brandon and Li, Daniel and Braganza, Sharon and Ratjen, Felix and Santyr, Giles},
  title = {Comparison of Single‐Breath and Multi‐Breath Xe‐ MRI in the Longitudinal Assessment of Treatment in Children With Cystic Fibrosis},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2026},
  doi = {10.1002/jmri.70242}
}
Kostenlos starten →